Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00681174Phase 4Terminated
Phase 4, randomised, double-blind trial of oxycodone in postoperative pain (2 arms), sponsored by University of Parma. Primary endpoint: Morphine consumption (intravenous titration in PACU + i.v. patient-controlled pump usage) at 48 hours. Started Jul 2008; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00681174.